The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Plendil 5 mg prolonged-release tablets



Glenwood GmbHPA2256/005/002

Main Information

Trade NamePlendil 5 mg prolonged-release tablets
Active SubstancesFelodipine
Dosage FormProlonged-release tablet
Licence HolderGlenwood GmbH
Licence NumberPA2256/005/002

Group Information

ATC CodeC08CA Dihydropyridine derivatives
C08CA02 felodipine

Status

License statusAuthorised
Licence Issued18/05/1998
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back